The French group's sharp slide is the clearest signal yet that high-end spending is cooling, and the sector's biggest players should take note.

Late-stage win sets up regulatory talks and could reshape how cancer is treated - and how biotech investors value mRNA platforms.

The journalist who exposed Theranos says the Oscar-buzzed film is art, not evidence, and the distinction matters for anyone weighing a founder's story.

The world's worst measles outbreak is spreading as routine vaccination falters. Here is why every country's immunization program should pay attention.